Annexon Biosciences announced the appointments of two industry executives to its leadership team. Effective immediately, Mario Saltarelli, M.D., Ph.D., joins as Chief Medical Officer, and Susan Kramer, Dr.P.H., joins as Vice President, Product Development. Dr. Saltarelli joins Annexon with career long leadership expertise in neurodegeneration drug development.

He most recently served as Senior Vice President and Chief Science Officer at Mallinckrodt Pharmaceuticals, and previously served as Senior Vice President of Research and Development at Shire. Dr. Kramer joins Annexon with extensive experience in product development and translational science. She most recently managed project and portfolio planning at KaloBios, and previously served as Vice President of Product Development at XOMA and Anesiva, respectively.